Results 91 to 100 of about 249 (106)

Discovery of Dotinurad (FYU-981), a New Phenol Derivative With Highly Potent Uric Acid Lowering Activity

open access: yesACS Medicinal Chemistry Letters, 2020
Junichiro Uda   +2 more
exaly   +2 more sources

Changes in Urinary Uric Acid Concentration After Dotinurad Administration to Patients With Hyperuricemia: A Post Hoc Analysis of Two Clinical Trials in Japan

open access: yesClinical Pharmacology in Drug Development
Abstract Dotinurad has been approved in Japan as a selective urate reabsorption inhibitor for the treatment of gout and hyperuricemia. The relationship between uric acid crystallization and the use of uricosuric drugs is widely acknowledged; however, the relationship between changes in urinary uric acid concentration and urine pH or volume has not been
Toshinari Takahashi
exaly   +2 more sources
Some of the next articles are maybe not open access.

Related searches:

Dotinurad: A Novel Selective Urate Reabsorption Inhibitor for the Treatment of Hyperuricemia and Gout

Expert Opinion on Pharmacotherapy, 2021
Tetsuya Taniguchi   +2 more
exaly  

Ideal Pharmacokinetic Profile of Dotinurad as a Selective Urate Reabsorption Inhibitor

Drug Metabolism and Pharmacokinetics, 2020
Junichiro Uda   +2 more
exaly  

Clinical Pharmacological Study of Dotinurad Administered to Male and Female Elderly or Young Subjects

Clinical and Experimental Nephrology, 2020
Tetsuo Ohashi, Tomomitsu Sasaki
exaly  

Home - About - Disclaimer - Privacy